Delivery Order SPE2DB25D3012-SPE2DB25FWZLL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,322.37 to AmerisourceBergen Drug Corp for SUNOSI 150 mg tablets (30-count supply) on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed price contract, placed through a non-set-aside competitive procurement, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the contractor's location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,624.77 to AmerisourceBergen Drug Corp for SUNOSI 150 mg tablets (30-count supply) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award involved no set-aside designation and was competitively awarded....
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company, to provide the SUNOSI 75 MG TABLET 30S medication. The contract has a potential value of $1,167.57 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this award, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SUNOSI 150 MG TABLET 30S. The contract has a firm fixed price of $3,803.85 and a period of performance through July 9, 2025. The order is not set-aside and represents an open competition award. AmerisourceBergen Drug Corp is a for-profit organization headquartered in Conshohocken, Pennsylvania and holds a significant Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,172.32 for 30 tablets of Sunosi 150 mg on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global...
- The Defense Logistics Agency awarded a $1,154.87 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Sunosi 150 mg tablets (30-count units). This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 13, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Sunosi 150 mg tablets (30-count units) with a contract value of $2,570.36 and a firm fixed price structure. This delivery order, valued at the ceiling amount specified, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The work is to be performed at the company's corporate office in Conshohocken, Pennsylvania, and the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Sunosi 150 mg tablets (30-count units) with a contract ceiling value of $2,746.87. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through competitive procurement. The contract is classified as a child award, meaning it derives from a larger indefinite delivery contract vehicle. Performance will be executed from the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,420.20 to AmerisourceBergen Drug Corp for the supply of Sunosi 75 mg tablets (30-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed price contract, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, the Corporate Office division of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The $1,386.78 contract is for the delivery of the pharmaceutical product SUNOSI 75 MG TABLET 30S through April 15, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWZLLDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of SUNOSI 150 mg tablets (30-count packages) under a firm fixed-price contract valued at $3,372.38. The award was issued on August 22, 2025, with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its Corporate Office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support federal military and veteran healthcare systems globally. The DLA Troop Support is planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen Drug Corp to continue serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 8/22/25 |